JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 15 November 2004. doi:10.1083/jcb.200407178
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 167, Number 4, 627-638
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2711K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espejel, S.
Right arrow Articles by Blasco, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espejel, S.
Right arrow Articles by Blasco, M. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs



Silvia Espejel1, Peter Klatt1, Josiane Ménissier-de Murcia2, Juan Martín-Caballero1, Juana M. Flores3, Guillermo Taccioli4, Gilbert de Murcia2, and María A. Blasco1

1 Molecular Oncology Program, Spanish National Cancer Center (CNIO), E-28029 Madrid, Spain
2 Ecole Supérieure de Biotechnologie, UPR9003/CNRS, BP 10413, F-67412 Illkirch Cedex, France
3 Animal Surgery and Medicine Department, Faculty of Veterinary Medicine, Complutense University of Madrid, E-28040 Madrid, Spain
4 Department of Microbiology, Boston University, Boston, MA 02118

Correspondence to María A. Blasco: mblasco{at}cnio.es

The DNA repair proteins poly(ADP-ribose) polymerase-1 (PARP-1), Ku86, and catalytic subunit of DNA-PK (DNA-PKcs) have been involved in telomere metabolism. To genetically dissect the impact of these activities on telomere function, as well as organismal cancer and aging, we have generated mice doubly deficient for both telomerase and any of the mentioned DNA repair proteins, PARP-1, Ku86, or DNA-PKcs. First, we show that abrogation of PARP-1 in the absence of telomerase does not affect the rate of telomere shortening, telomere capping, or organismal viability compared with single telomerase-deficient controls. Thus, PARP-1 does not have a major role in telomere metabolism, not even in the context of telomerase deficiency. In contrast, mice doubly deficient for telomerase and either Ku86 or DNA-PKcs manifest accelerated loss of organismal viability compared with single telomerase-deficient mice. Interestingly, this loss of organismal viability correlates with proliferative defects and age-related pathologies, but not with increased incidence of cancer. These results support the notion that absence of telomerase and short telomeres in combination with DNA repair deficiencies accelerate the aging process without impacting on tumorigenesis.

Abbreviations used in this paper: DNA-PK, DNA-dependent protein kinase; DNA-PKcs, catalytic subunit of DNA-PK; DSB, double-strand break; MEF, mouse embryonic fibroblast; NHEJ, nonhomologous end joining; PARP-1, poly(ADP-ribose) polymerase-1; Terc, telomerase RNA component.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents